The US Food and Drug Administration (FDA), and the European Medicines Agency (EMA) have agreed to review Novartis’ applications of...
Read More...
The post Novartis seeks approval for ofatumumab to treat multiple sclerosis appeared first on Pharmaceutical Technology.
Original Article: Novartis seeks approval for ofatumumab to treat multiple sclerosis